Rare apolipoprotein E variant identified in a patient with type III hyperlipidaemia.
We report a rare apolipoprotein E variant in an Irish female with Type III hyperlipidaemia who has the phenotype E2E1 as determined by isoelectric focusing. Sequence analysis of the apolipoprotein E gene from the proband and from four other family members, using DNA amplified by the polymerase chain reaction, demonstrated the presence of a point mutation in the common epsilon 2 allele with a G-->A transition at nucleotide 3791. This was confirmed by digestion with the restriction endonuclease TaqI, which cuts at a new site within the apolipoprotein E gene, created by the base change. This mutation results in a substitution of aspartic acid for glycine at position 127 of the mature protein. We believe this to be the first description of this apolipoprotein E variant in a family from the British Isles. The mutation appears to be 'recessive' with respect to the expression of Type III hyperlipidaemia, although it may be somewhat more potent in this regard than the parent epsilon 2 allele. The Type III hyperlipidaemia is responsive to treatment with diet and gemfibrozil.
Department of Clinical Biochemistry, Western General Hospital, Edinburgh, UK.
P R
PR
Wenham
I F
IF
McDowell
V M
VM
Hodges
J
J
McEneny
M J
MJ
O'Kane
R J
RJ
Davies
D P
DP
Nicholls
E R
ER
Trimble
G
G
Blundell
D000328:Adult; D001057:Apolipoproteins E / Q000235:genetics*; D001483:Base Sequence; D004247:DNA / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D006949:Hyperlipidemias / Q000235:genetics* / Q000378:metabolism; D015151:Immunoblotting; D007525:Isoelectric Focusing; D008969:Molecular Sequence Data; D009154:Mutation; D010375:Pedigree; D010641:Phenotype
D001057:Apolipoproteins E; D004247:DNA